Authors: ANDREASSON P HOGLUND M JONSON T BEKASSY A MITELMAN F JOHANSSON B

Citation: P. Andreasson et al., MOLECULAR CHARACTERIZATION OF JUMPING TRANSLOCATIONS REVEALS SPATIAL AND TEMPORAL BREAKPOINT HETEROGENEITY, Leukemia, 12(9), 1998, pp. 1411-1416

Authors: DALLORSO S SERRA IB BARANZELLI MC BEKASSY A BEGUIN Y BIRON P CASTEL V DEVALCK C FASTH A HARTMANN O HERO B KOSCIELNIAK E KREMENS B MICHON J NIEDERWEISER D NIETHAMMER D REMES K FERRANTE P ROSTI G

Citation: S. Dallorso et al., HIGH-DOSE THERAPY (HDT) WITH STEM-CELL RESCUE IN POOR-RISK WILMS-TUMOR (WT) - AN EBMT SOLID TUMOR WP REGISTRY UPDATE AT JUNE 1997, Bone marrow transplantation, 21, 1998, pp. 806-806

Authors: HASSAN M OBERG G LJUNGMAN P SANDSTROM M BEKASSY A KARLSSON M JONSSON N RINGDEN O

Citation: M. Hassan et al., CORRELATION BETWEEN HEPATIC VENOOCCLUSIVE DISEASE (VOD) AND BUSULFAN LEVELS USING LIMITED SAMPLING MODEL FOR DOSE ESTIMATION, Blood, 90(10), 1997, pp. 1106-1106

Authors: SCHWARTZ M BEKASSY A DONNER M HERTEL T HREIDARSON S KERNDRUP G STORMORKEN H STOKLAND T TRANEBJAERG L ORSTAVIK KH SKOVBY F

Citation: M. Schwartz et al., MUTATION SPECTRUM IN PATIENTS WITH WISKOTT-ALDRICH SYNDROME AND X-LINKED THROMBOCYTOPENIA - IDENTIFICATION OF 12 DIFFERENT MUTATIONS IN THEWASP GENE, Thrombosis and haemostasis, 75(4), 1996, pp. 546-550

Authors: HASSAN M LJUNGMAN P BOLME P RINGDEN O SYRUCKOVA Z BEKASSY A STARY J WALLIN I KALLBERG N

Citation: M. Hassan et al., BUSULFAN BIOAVAILABILITY, Blood, 84(7), 1994, pp. 2144-2150